Synthesis, crystal structure, and Hirschfeld surface analysis of novel ethyl 5-bromo-2-(4-methoxyphenyl) oxazole-4-carboxylate
10.14805/jphchem.2023.art297

Keywords

oxazole
NMR
mass spectroscopy
single-crystal X-ray diffraction
Hirschfeld surface analysis
two-dimensional fingerprint plots

How to Cite

(1)
Murtuja, S.; Jayaprakash, V.; Sinha, B. N. Synthesis, Crystal Structure, and Hirschfeld Surface Analysis of Novel Ethyl 5-Bromo-2-(4-Methoxyphenyl) Oxazole-4-Carboxylate. J Pharm Chem 2023, 9.

Abstract

A new oxazole derivative, ethyl 5-bromo-2-(4-methoxyphenyl) oxazole-4-carboxylate, was synthesized and characterized by IR spectroscopy, 13C NMR, Mass spectroscopy, and single-crystal X-ray diffraction analysis. The asymmetric unit of the title compound has two independent molecules (A and B) arranged in an inverted planar orientation, stabilized by intramolecular C-H…O and C-H…N hydrogen bonds and intermolecular C-H…O hydrogen bonds. The crystallographic parameter for the structure C13H12BrNO4 is =326.15 g/mol, monoclinic, sp. gr. P21/n (no. 14), a = 14.828(2) Å, b = 7.1335(9) Å, c = 25.119(2) Å, β = 100.066(11) °, = 2616.1(6) Å3, Z = 8. Hirschfeld surface analysis and two-dimensional fingerprint plots provided insight into the short intermolecular interactions, and it was found that H···H (34.4%) interactions contributed the most to the intermolecular interactions. In contrast, the contribution of C · · · C (2.5 %) remained the least among all the interactions.

https://doi.org/10.14805/jphchem.2023.art297
10.14805/jphchem.2023.art297

References

I.H.R. Tomi, J.H. Tomma, A.H.R. Al-Daraji, A.H. Al-Dujaili, Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds containing oxazole and benzothiazole moieties, J. Saudi Chem. Soc. 19 (2015) 392–398. https://doi.org/10.1016/j.jscs.2012.04.010.

V. Škedelj, A. Perdih, M. Brvar, A. Kroflič, V. Dubbée, V. Savage, A.J. O’Neill, T. Solmajer, M. Bešter-Rogač, D. Blanot, J.E. Hugonnet, S. Magnet, M. Arthur, J.L. Mainardi, J. Stojan, A. Zega, Discovery of the first inhibitors of bacterial enzyme D-aspartate ligase from Enterococcus faecium (Aslfm), Eur. J. Med. Chem. 67 (2013) 208–220. https://doi.org/10.1016/j.ejmech.2013.06.017.

N. Li, Y. Xu, Q. Xia, C. Bai, T. Wang, L. Wang, D. He, N. Xie, L. Li, J. Wang, H.G. Zhou, F. Xu, C. Yang, Q. Zhang, Z. Yin, Y. Guo, Y. Chen, Simplified captopril analogues as NDM-1 inhibitors, Bioorganic Med. Chem. Lett. 24 (2014) 386–389. https://doi.org/10.1016/j.bmcl.2013.10.068.

N.R. Stokes, N. Baker, J.M. Bennett, P.K. Chauhan, I. Collins, D.T. Davies, M. Gavade, D. Kumar, P. Lancett, R. Macdonald, L. Macleod, A. Mahajan, J.P. Mitchell, N. Nayal, Y.N. Nayal, G.R.W. Pitt, M. Singh, A. Yadav, A. Srivastava, L.G. Czaplewski, D.J. Haydon, Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ, Bioorganic Med. Chem. Lett. 24 (2014) 353–359. https://doi.org/10.1016/j.bmcl.2013.11.002.

T. Bhanu Prakash, G. Dinneswara Reddy, A. Padmaja, V. Padmavathi, Synthesis and antimicrobial activity of amine linked bis- and tris-heterocycles, Eur. J. Med. Chem. 82 (2014) 347–354. https://doi.org/10.1016/j.ejmech.2014.06.001.

P.C. Patil, J. Tan, D.R. Demuth, F.A. Luzzio, 1,2,3-Triazole-based inhibitors of Porphyromonas gingivalis adherence to oral streptococci and biofilm formation, Bioorganic Med. Chem. 24 (2016) 5410–5417. https://doi.org/10.1016/j.bmc.2016.08.059.

J.L. Bell, A.J. Haak, S.M. Wade, P.D. Kirchhoff, R.R. Neubig, S.D. Larsen, Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents, Bioorganic Med. Chem. Lett. 23 (2013) 3826–3832. https://doi.org/10.1016/j.bmcl.2013.04.080.

S. Naud, I.M. Westwood, A. Faisal, P. Sheldrake, V. Bavetsias, B. Atrash, K.M.J. Cheung, M. Liu, A. Hayes, J. Schmitt, A. Wood, V. Choi, K. Boxall, G. Mak, M. Gurden, M. Valenti, A. De Haven Brandon, A. Henley, R. Baker, C. McAndrew, B. Matijssen, R. Burke, S. Hoelder, S.A. Eccles, F.I. Raynaud, S. Linardopoulos, R.L.M. Van Montfort, J. Blagg, Structure-based design of orally bioavailable 1 h -Pyrrolo[3,2- C ]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1), J. Med. Chem. 56 (2013) 10045–10065. https://doi.org/10.1021/jm401395s.

S.W. Rafferty, J.R. Eisner, W.R. Moore, R.J. Schotzinger, W.J. Hoekstra, Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors, Bioorganic Med. Chem. Lett. 24 (2014) 2444–2447. https://doi.org/10.1016/j.bmcl.2014.04.024.

H.Y. Zhu, J. Desai, Y. Deng, A. Cooper, J. Wang, J. Shipps, A. Samatar, D. Carr, W. Windsor, Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitors, Bioorganic Med. Chem. Lett. 25 (2015) 1627–1629. https://doi.org/10.1016/j.bmcl.2015.01.049.

M.S.C. Pedras, A. Abdoli, Metabolism of the phytoalexins camalexins, their bioisosteres and analogues in the plant pathogenic fungus Alternaria brassicicola, Bioorganic Med. Chem. 21 (2013) 4541–4549. https://doi.org/10.1016/j.bmc.2013.05.026.

M.Z. Zhang, Q. Chen, C.H. Xie, N. Mulholland, S. Turner, D. Irwin, Y.C. Gu, G.F. Yang, J. Clough, Synthesis and antifungal activity of novel streptochlorin analogues, Eur. J. Med. Chem. 92 (2015) 776–783. https://doi.org/10.1016/j.ejmech.2015.01.043.

M. De La Fuente Revenga, N. Fernández-Sáez, C. Herrera-Arozamena, J.A. Morales-García, S. Alonso-Gil, A. Pérez-Castillo, D.H. Caignard, S. Rivara, M.I. Rodríguez-Franco, Novel N -Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential, J. Med. Chem. 58 (2015) 4998–5014. https://doi.org/10.1021/acs.jmedchem.5b00245.

M. Gobec, T. Tomašič, T. Markovič, I. Mlinarič-Raščan, M.S. Dolenc, Ž. Jakopin, Antioxidant and anti-inflammatory properties of 1,2,4-oxadiazole analogs of resveratrol, Chem. Biol. Interact. 240 (2015) 200–207. https://doi.org/10.1016/j.cbi.2015.08.018.

L. Ferrins, R. Rahmani, M.L. Sykes, A.J. Jones, V.M. Avery, E. Teston, B. Almohaywi, J.X. Yin, J. Smith, C. Hyland, K.L. White, E. Ryan, M. Campbell, S.A. Charman, M. Kaiser, J.B. Baell, 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis, Eur. J. Med. Chem. 66 (2013) 450–465. https://doi.org/10.1016/j.ejmech.2013.05.007.

D. Yamamuro, R. Uchida, M. Ohtawa, S. Arima, Y. Futamura, M. Katane, H. Homma, T. Nagamitsu, H. Osada, H. Tomoda, Synthesis and biological activity of 5-(4-methoxyphenyl)-oxazole derivatives, Bioorganic Med. Chem. Lett. 25 (2015) 313–316. https://doi.org/10.1016/j.bmcl.2014.11.042.

S.K. Chakka, M. Kalamuddin, S. Sundararaman, L. Wei, S. Mundra, R. Mahesh, P. Malhotra, A. Mohmmed, L.P. Kotra, Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents, Bioorganic Med. Chem. 23 (2015) 2221–2240. https://doi.org/10.1016/j.bmc.2015.02.062.

A. Meissner, H.I. Boshoff, M. Vasan, B.P. Duckworth, C.E. Barry, C.C. Aldrich, Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis, Bioorganic Med. Chem. 21 (2013) 6385–6397. https://doi.org/10.1016/j.bmc.2013.08.048.

J. Franke, M. Bock, R. Dehn, J. Fohrer, S.B. Mhaske, A. Migliorini, A.A. Kanakis, R. Jansen, J. Herrmann, R. Müller, A. Kirschning, Total and semi-syntheses of antimicrobial thuggacin derivatives, Chem. - A Eur. J. 21 (2015) 4272–4284. https://doi.org/10.1002/chem.201405874.

D. Li, N. Gao, N. Zhu, Y. Lin, Y. Li, M. Chen, X. You, Y. Lu, K. Wan, J.D. Jiang, W. Jiang, S. Si, Discovery of the disubstituted oxazole analogues as a novel class anti-tuberculotic agents against MDR- and XDR-MTB, Bioorganic Med. Chem. Lett. 25 (2015) 5178–5181. https://doi.org/10.1016/j.bmcl.2015.09.072.

Y.K. Abhale, A. V. Sasane, A.P. Chavan, S.H. Shekh, K.K. Deshmukh, S. Bhansali, L. Nawale, D. Sarkar, P.C. Mhaske, Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives, Eur. J. Med. Chem. 132 (2017) 333–340. https://doi.org/10.1016/j.ejmech.2017.03.065.

T. Wang, Z. Yang, Z. Zhang, Y.F. Gong, K.A. Riccardi, P.F. Lin, D.D. Parker, S. Rahematpura, M. Mathew, M. Zheng, N.A. Meanwell, J.F. Kadow, J.A. Bender, Inhibitors of HIV-1 attachment. Part 10. the discovery and structure-activity relationships of 4-azaindole cores, Bioorganic Med. Chem. Lett. 23 (2013) 213–217. https://doi.org/10.1016/j.bmcl.2012.10.120.

A. Regueiro-Ren, Q.M. Xue, J.J. Swidorski, Y.F. Gong, M. Mathew, D.D. Parker, Z. Yang, B. Eggers, C. D’Arienzo, Y. Sun, J. Malinowski, Q. Gao, D. Wu, D.R. Langley, R.J. Colonno, C. Chien, D.M. Grasela, M. Zheng, P.F. Lin, N.A. Meanwell, J.F. Kadow, Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4- fluoro-7-[1,2,3]triazol-1-yl-1H-, J. Med. Chem. 56 (2013) 1656–1669. https://doi.org/10.1021/jm3016377.

S.H. Kim, B. Markovitz, R. Trovato, B.R. Murphy, H. Austin, A.J. Willardsen, V. Baichwal, S. Morham, A. Bajji, Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles, Bioorganic Med. Chem. Lett. 23 (2013) 2888–2892. https://doi.org/10.1016/j.bmcl.2013.03.075.

D.R. St. Laurent, M.H. Serrano-Wu, M. Belema, M. Ding, H. Fang, M. Gao, J.T. Goodrich, R.G. Krause, J.A. Lemm, M. Liu, O.D. Lopez, V.N. Nguyen, P.T. Nower, D.R. O’Boyle, B.C. Pearce, J.L. Romine, L. Valera, J.H. Sun, Y.K. Wang, F. Yang, X. Yang, N.A. Meanwell, L.B. Snyder, HCV NS5A replication complex inhibitors. Part 4.1 optimization for genotype 1a replicon inhibitory activity, J. Med. Chem. 57 (2014) 1976–1994. https://doi.org/10.1021/jm301796k.

I.F. Sevrioukova, T.L. Poulos, Pyridine-substituted desoxyritonavir is a more potent inhibitor of cytochrome P450 3A4 than ritonavir, J. Med. Chem. 56 (2013) 3733–3741. https://doi.org/10.1021/jm400288z.

Z.J. Zhong, D.J. Zhang, Z.G. Peng, Y.H. Li, G.Z. Shan, L.M. Zuo, L.T. Wu, S.Y. Li, R.M. Gao, Z.R. Li, Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines, Eur. J. Med. Chem. 69 (2013) 32–43. https://doi.org/10.1016/j.ejmech.2013.07.053.

E.P. Keaney, M. Connolly, M. Dobler, R. Karki, A. Honda, S. Sokup, S. Karur, S. Britt, A. Patnaik, P. Raman, L.G. Hamann, B. Wiedmann, M.J. Lamarche, 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication, Bioorganic Med. Chem. Lett. 24 (2014) 3714–3718. https://doi.org/10.1016/j.bmcl.2014.07.015.

A.G. Draffan, B. Frey, B.H. Fraser, B. Pool, C. Gannon, E.M. Tyndall, J. Cianci, M. Harding, M. Lilly, R. Hufton, R. Halim, S. Jahangiri, S. Bond, T.P. Jeynes, V.T.T. Nguyen, V. Wirth, A. Luttick, D. Tilmanis, M. Pryor, K. Porter, C.J. Morton, B. Lin, J. Duan, R.C. Bethell, G. Kukolj, B. Simoneau, S.P. Tucker, Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents, Bioorganic Med. Chem. Lett. 24 (2014) 4984–4988. https://doi.org/10.1016/j.bmcl.2014.09.030.

M. Belema, V.N. Nguyen, J.L. Romine, D.R. St. Laurent, O.D. Lopez, J.T. Goodrich, P.T. Nower, D.R. O’Boyle, J.A. Lemm, R.A. Fridell, M. Gao, H. Fang, R.G. Krause, Y.K. Wang, A.J. Oliver, A.C. Good, J.O. Knipe, N.A. Meanwell, L.B. Snyder, Hepatitis C virus NS5A replication complex inhibitors. Part 6: Discovery of a novel and highly potent biarylimidazole chemotype with inhibitory activity toward genotypes 1a and 1b replicons, J. Med. Chem. 57 (2014) 1995–2012. https://doi.org/10.1021/jm4016203.

G. Romano, L. It, S. Tiseni, M.I.T. Gianpaolo, ( 12 ) Patent Application Publication ( 10 ) Pub . No .: US 2006 / 0211603 A1, 2006.

O. V. Dolomanov, L.J. Bourhis, R.J. Gildea, J.A.K. Howard, H. Puschmann, OLEX2: A complete structure solution, refinement and analysis program, J. Appl. Crystallogr. 42 (2009) 339–341. https://doi.org/10.1107/S0021889808042726.

L.J. Bourhis, O. V. Dolomanov, R.J. Gildea, J.A.K. Howard, H. Puschmann, The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment - Olex2 dissected, Acta Crystallogr. Sect. A Found. Crystallogr. 71 (2015) 59–75. https://doi.org/10.1107/S2053273314022207.

G.M. Sheldrick, Crystal structure refinement with SHELXL, Acta Crystallogr. Sect. C Struct. Chem. 71 (2015) 3–8. https://doi.org/10.1107/S2053229614024218.

L.J. Farrugia, WinGX and ORTEP for Windows: An update, J. Appl. Crystallogr. 45 (2012) 849–854. https://doi.org/10.1107/S0021889812029111.

C.F. Macrae, I.J. Bruno, J.A. Chisholm, P.R. Edgington, P. McCabe, E. Pidcock, L. Rodriguez-Monge, R. Taylor, J. Van De Streek, P.A. Wood, Mercury CSD 2.0 - New features for the visualization and investigation of crystal structures, J. Appl. Crystallogr. 41 (2008) 466–470. https://doi.org/10.1107/S0021889807067908.

M.A. Spackman, D. Jayatilaka, Hirschfeld surface analysis, CrystEngComm. 11 (2009) 19–32. https://doi.org/10.1039/b818330a.

J.J. McKinnon, D. Jayatilaka, M.A. Spackman, Towards quantitative analysis of intermolecular interactions with Hirschfeld surfaces, Chem. Commun. (2007) 3814–3816. https://doi.org/10.1039/b704980c.

M.A. Wolff, G. SK, M. DJ, T. JJ, J. MJ, D. and Spackman, 2012, Crystal Explorer 17.5, Univ. West. Austr. (n.d.).

M.A. Spackman, J.J. McKinnon, Fingerprinting intermolecular interactions in molecular crystals, CrystEngComm. 4 (2002) 378–392. https://doi.org/10.1039/b203191b.

J.J. McKinnon, M.A. Spackman, A.S. Mitchell, Novel tools for visualizing and exploring intermolecular interactions in molecular crystals, 2004. https://doi.org/10.1107/S0108768104020300.

R.R. Ternavisk, A.J. Camargo, F.B.C. Machado, H.B. Napolitano, Synthesis , characterization , and computational study of a new dimethoxy-chalcone, J. Mol. Model. (2014) 2526–2536. https://doi.org/10.1007/s00894-014-2526-8.

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2023 Journal of Pharmaceutical Chemistry

Metrics

Metrics Loading ...